US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist
  • 9.2300
  • +0.4400+5.01%
Close Sep 27 16:00 ET
  • 9.2300
  • 0.00000.00%
Post 20:02 ET
97.43MMarket Cap-1675P/E (TTM)

Benitec Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.72%-19.4M
19.58%-3.29M
-53.09%-6.17M
8.18%-5.37M
-13.15%-4.58M
-13.29%-18.01M
15.65%-4.1M
-17.74%-4.03M
-74.73%-5.84M
5.45%-4.05M
Net income from continuing operations
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.30%-4.4M
-12.21%-5.41M
-0.95%-5.09M
Depreciation and amortization
-9.97%343K
8.33%91K
-3.23%90K
-21.57%80K
-19.61%82K
-2.81%381K
33.33%84K
-18.42%93K
-9.73%102K
0.00%102K
Change In working capital
64.43%1.17M
147.75%882K
-1,185.50%-2.17M
357.46%1.26M
86.09%1.2M
-31.15%714K
1,973.68%356K
143.57%200K
-144.33%-489K
57.04%647K
-Change in receivables
-252.00%-176K
---176K
--0
----
----
-5,100.00%-50K
--0
--0
----
----
-Change in prepaid assets
255.80%645K
-1.50%-406K
151.00%205K
-18.45%137K
222.27%709K
-767.74%-414K
26.87%-400K
---402K
--168K
--220K
-Change in payables and accrued expense
-31.47%980K
87.07%1.53M
-446.92%-2.31M
318.93%1.19M
14.93%562K
31.19%1.43M
41.87%820K
205.72%665K
-164.15%-544K
66.89%489K
-Change in other current liabilities
-9.13%-275K
-9.38%-70K
-9.52%-69K
-9.52%-69K
-8.06%-67K
-28.57%-252K
-14.29%-64K
-43.18%-63K
-43.18%-63K
-19.23%-62K
Cash from discontinued investing activities
Operating cash flow
-7.72%-19.4M
19.58%-3.29M
-53.09%-6.17M
8.18%-5.37M
-13.15%-4.58M
-13.29%-18.01M
15.65%-4.1M
-17.74%-4.03M
-74.73%-5.84M
5.45%-4.05M
Investing cash flow
Cash flow from continuing investing activities
-17,800.00%-179K
0
92.31%-1K
-1K
Net PPE purchase and sale
-17,800.00%-179K
--0
----
----
----
92.31%-1K
---1K
----
----
----
Cash from discontinued investing activities
Investing cash flow
-17,800.00%-179K
--0
---179K
--0
--0
92.31%-1K
---1K
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
324.78%68.03M
40.07M
0
39K
74.33%27.92M
16.02M
0
0
0
16.02M
Net common stock issuance
313.34%73.92M
--43M
--0
--39K
72.69%30.88M
--17.88M
--0
--0
--0
--17.88M
Net other financing activities
-215.25%-5.89M
---2.93M
--0
--0
-58.59%-2.96M
---1.87M
--0
--0
--0
---1.87M
Cash from discontinued financing activities
Financing cash flow
324.78%68.03M
--40.07M
--0
--39K
74.33%27.92M
--16.02M
--0
--0
--0
--16.02M
Net cash flow
Beginning cash position
-38.91%2.49M
115.63%14.16M
93.23%20.39M
56.38%25.88M
-38.91%2.49M
-79.40%4.08M
-23.93%6.57M
-14.52%10.55M
5.12%16.55M
-79.40%4.08M
Current changes in cash
2,524.77%48.45M
997.90%36.78M
-57.53%-6.35M
8.85%-5.33M
95.00%23.34M
87.44%-2M
15.86%-4.1M
-17.74%-4.03M
-74.73%-5.84M
379.80%11.97M
Effect of exchange rate changes
-101.94%-8K
-123.81%-5K
167.44%115K
-6.54%-163K
-91.02%45K
101.96%412K
-92.98%21K
115.52%43K
-183.33%-153K
112.29%501K
End cash Position
1,945.34%50.93M
1,945.34%50.93M
115.63%14.16M
93.23%20.39M
56.38%25.88M
-38.91%2.49M
-38.91%2.49M
-23.93%6.57M
-14.52%10.55M
5.12%16.55M
Free cash flow
-8.71%-19.58M
19.60%-3.29M
-57.53%-6.35M
8.18%-5.37M
-13.15%-4.58M
-13.20%-18.01M
15.86%-4.1M
-17.74%-4.03M
-74.73%-5.84M
5.45%-4.05M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.72%-19.4M19.58%-3.29M-53.09%-6.17M8.18%-5.37M-13.15%-4.58M-13.29%-18.01M15.65%-4.1M-17.74%-4.03M-74.73%-5.84M5.45%-4.05M
Net income from continuing operations -11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.30%-4.4M-12.21%-5.41M-0.95%-5.09M
Depreciation and amortization -9.97%343K8.33%91K-3.23%90K-21.57%80K-19.61%82K-2.81%381K33.33%84K-18.42%93K-9.73%102K0.00%102K
Change In working capital 64.43%1.17M147.75%882K-1,185.50%-2.17M357.46%1.26M86.09%1.2M-31.15%714K1,973.68%356K143.57%200K-144.33%-489K57.04%647K
-Change in receivables -252.00%-176K---176K--0---------5,100.00%-50K--0--0--------
-Change in prepaid assets 255.80%645K-1.50%-406K151.00%205K-18.45%137K222.27%709K-767.74%-414K26.87%-400K---402K--168K--220K
-Change in payables and accrued expense -31.47%980K87.07%1.53M-446.92%-2.31M318.93%1.19M14.93%562K31.19%1.43M41.87%820K205.72%665K-164.15%-544K66.89%489K
-Change in other current liabilities -9.13%-275K-9.38%-70K-9.52%-69K-9.52%-69K-8.06%-67K-28.57%-252K-14.29%-64K-43.18%-63K-43.18%-63K-19.23%-62K
Cash from discontinued investing activities
Operating cash flow -7.72%-19.4M19.58%-3.29M-53.09%-6.17M8.18%-5.37M-13.15%-4.58M-13.29%-18.01M15.65%-4.1M-17.74%-4.03M-74.73%-5.84M5.45%-4.05M
Investing cash flow
Cash flow from continuing investing activities -17,800.00%-179K092.31%-1K-1K
Net PPE purchase and sale -17,800.00%-179K--0------------92.31%-1K---1K------------
Cash from discontinued investing activities
Investing cash flow -17,800.00%-179K--0---179K--0--092.31%-1K---1K--0--0--0
Financing cash flow
Cash flow from continuing financing activities 324.78%68.03M40.07M039K74.33%27.92M16.02M00016.02M
Net common stock issuance 313.34%73.92M--43M--0--39K72.69%30.88M--17.88M--0--0--0--17.88M
Net other financing activities -215.25%-5.89M---2.93M--0--0-58.59%-2.96M---1.87M--0--0--0---1.87M
Cash from discontinued financing activities
Financing cash flow 324.78%68.03M--40.07M--0--39K74.33%27.92M--16.02M--0--0--0--16.02M
Net cash flow
Beginning cash position -38.91%2.49M115.63%14.16M93.23%20.39M56.38%25.88M-38.91%2.49M-79.40%4.08M-23.93%6.57M-14.52%10.55M5.12%16.55M-79.40%4.08M
Current changes in cash 2,524.77%48.45M997.90%36.78M-57.53%-6.35M8.85%-5.33M95.00%23.34M87.44%-2M15.86%-4.1M-17.74%-4.03M-74.73%-5.84M379.80%11.97M
Effect of exchange rate changes -101.94%-8K-123.81%-5K167.44%115K-6.54%-163K-91.02%45K101.96%412K-92.98%21K115.52%43K-183.33%-153K112.29%501K
End cash Position 1,945.34%50.93M1,945.34%50.93M115.63%14.16M93.23%20.39M56.38%25.88M-38.91%2.49M-38.91%2.49M-23.93%6.57M-14.52%10.55M5.12%16.55M
Free cash flow -8.71%-19.58M19.60%-3.29M-57.53%-6.35M8.18%-5.37M-13.15%-4.58M-13.20%-18.01M15.86%-4.1M-17.74%-4.03M-74.73%-5.84M5.45%-4.05M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data